共 37 条
[1]
Ruibal Morell A(1992)CEA serum levels in non-neoplastic disease Int J Biol Markers 7 160-166
[2]
Ballehaninna UK(2011)Serum CA 19–9 as a biomarker for pancreatic cancer-a comprehensive review Indian J Surg Oncol 2 88-100
[3]
Chamberlain RS(1978)Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer N Engl J Med 299 448-451
[4]
Wanebo HJ(2019)Prognostic potential of circulating tumor DNA measurement in postoperative surveillance of nonmetastatic colorectal cancer JAMA Oncol 5 1118-1123
[5]
Wang Y(2005)Detection and quantification of mutations in the plasma of patients with colorectal tumors Proc Natl Acad Sci 102 16368-16373
[6]
Diehl F(2008)Circulating mutant DNA to assess tumor dynamics Nat Med 14 985-990
[7]
Diehl F(2010)Circulating tumour cells in cancer patients: challenges and perspectives Trends Mol Med 16 398-406
[8]
Pantel K(2020)ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper Nat Rev Clin Oncol 17 757-770
[9]
Alix-Panabieres C(2013)Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA Nature 497 108-112
[10]
Dasari A(2018)Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review Arch Pathol Lab Med 142 1242-1253